We are raising $10 million in the first raise (near series A) for a Biotech company, that has five use cases (different chemistry) all based on a specific molecule. The solutions are all in assistance to treat Cancer (four specific use types), Sepsis and three other applications. The overall intention is to raise up to $50 million where their exit is to flip to big pharma, which they have done in their past.